Taipei, Taiwan

Fang-Chi Hsu

This inventor holds 2 USPTO granted patents. Top assignee: Taipei Medical University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fang-Chi Hsu. Retrieved from https://idiyas.com/inventor/fang-chi-hsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fang-Chi Hsu: Innovator in Tumor Cell Capture Technology

Introduction

Fang-Chi Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical technology, particularly in the capture of tumor cells for cancer diagnosis and research. His innovative work has led to the development of methods that can enhance the identification and treatment of cancer.

Latest Patents

Fang-Chi Hsu holds 2 patents related to his groundbreaking work. His latest patents include a kit and method for the capture of tumor cells in body fluid samples. This invention allows for the capture of living tumor cells while excluding non-living tumor cells or cell fragments. The captured tumor cells can be cultured for further identification, aiding in the detection of cancer and monitoring the development of metastasis and early relapse.

Career Highlights

Hsu is affiliated with Taipei Medical University, where he continues to advance his research and innovations. His work is pivotal in improving cancer diagnostics and treatment methodologies.

Collaborations

Fang-Chi Hsu collaborates with Richard Li-Chern Pan, contributing to the advancement of their shared research interests in tumor cell capture technology.

Conclusion

Fang-Chi Hsu's contributions to the field of cancer research through his innovative patents are invaluable. His work not only enhances the understanding of tumor biology but also paves the way for improved cancer diagnostics and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…